These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35133552)

  • 1. Cardiorenal syndrome: long road between kidney and heart.
    Junho CVC; Trentin-Sonoda M; Panico K; Dos Santos RSN; Abrahão MV; Vernier ICS; Fürstenau CR; Carneiro-Ramos MS
    Heart Fail Rev; 2022 Nov; 27(6):2137-2153. PubMed ID: 35133552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome.
    Ma K; Gao W; Xu H; Liang W; Ma G
    J Renin Angiotensin Aldosterone Syst; 2022; 2022():3239057. PubMed ID: 35111237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.
    Napoli C; Casamassimi A; Crudele V; Infante T; Abbondanza C
    Future Cardiol; 2011 Jul; 7(4):485-97. PubMed ID: 21797745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
    Cabandugama PK; Gardner MJ; Sowers JR
    Med Clin North Am; 2017 Jan; 101(1):129-137. PubMed ID: 27884224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?
    Rubattu S; Mennuni S; Testa M; Mennuni M; Pierelli G; Pagliaro B; Gabriele E; Coluccia R; Autore C; Volpe M
    Int J Mol Sci; 2013 Nov; 14(11):23011-32. PubMed ID: 24264044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
    Giam B; Kaye DM; Rajapakse NW
    Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorenal Syndrome in Acute Kidney Injury.
    Di Lullo L; Reeves PB; Bellasi A; Ronco C
    Semin Nephrol; 2019 Jan; 39(1):31-40. PubMed ID: 30606406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiorenal Syndrome Revisited.
    Zannad F; Rossignol P
    Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAAS inhibition and cardiorenal syndrome.
    Onuigbo MA
    Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome.
    Clementi A; Virzì GM; Battaglia GG; Ronco C
    Cardiorenal Med; 2019; 9(5):265-273. PubMed ID: 31266023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal syndrome.
    Ronco C; Di Lullo L
    Heart Fail Clin; 2014 Apr; 10(2):251-80. PubMed ID: 24656104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Organ damage and cardiorenal syndrome in acute heart failure].
    Casado Cerrada J; Pérez Calvo JI
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():26-31. PubMed ID: 24930080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of cardiorenal syndrome: a review.
    Szymanski MK; de Boer RA; Navis GJ; van Gilst WH; Hillege HL
    Heart Fail Rev; 2012 May; 17(3):411-20. PubMed ID: 21909828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.
    Patel KP; Katsurada K; Zheng H
    Circ Res; 2022 May; 130(10):1601-1617. PubMed ID: 35549375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal protection during chronic renin-angiotensin-aldosterone system suppression: evidences and caveats.
    Ruiz-Hurtado G; Ruilope LM
    Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):126-31. PubMed ID: 27533982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic therapies for chronic and acute decompensated heart failure: specific insights on cardiorenal syndromes.
    Roubille F; Morena M; Leray-Moragues H; Canaud B; Cristol JP; Klouche K
    Blood Purif; 2014; 37 Suppl 2():20-33. PubMed ID: 25196566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Mehta RL; Rabb H; Shaw AD; Singbartl K; Ronco C; McCullough PA; Kellum JA
    Contrib Nephrol; 2013; 182():174-94. PubMed ID: 23689662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
    Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome.
    Du Y; Li X; Liu B
    Life Sci; 2014 Mar; 99(1-2):1-6. PubMed ID: 24140889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.